Clinical Trials Directory

Trials / Unknown

UnknownNCT02416609

Low-dose Radiotherapy Plus Chemotherapy With Gem-based Doublets and Stereotactic Radiotherapy for Advanced Pancreatic Cancer

Low-dose Radiotherapy as a Chemo-potentiator of a Induction Chemotherapy Regimen With Gem-based Doublets and Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
44 (estimated)
Sponsor
Azienda Ospedaliero-Universitaria di Modena · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Aim of this study is to evaluate if low-dose radiotherapy (LDR) can intensify local effect of a chemotherapy regimen with Gem-based doublets administered sequentially with stereotactic body radiotherapy (SBRT) and to assess the safety and efficacy of this combined treatment on patients affected by locally advanced pancreatic adenocarcinoma (LAPC).

Conditions

Interventions

TypeNameDescription
RADIATIONLDRLDR will be delivered during each cycle of Gem-based doublets
DRUGGem-based doublets4 cycles of Gem-based doublets
RADIATIONSBRTSBRT will be administered after the fourth Gem-based doblet cycle, if no progression; three fractions will be administered

Timeline

Start date
2014-01-01
Primary completion
2023-11-01
Completion
2024-11-01
First posted
2015-04-15
Last updated
2022-12-12

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT02416609. Inclusion in this directory is not an endorsement.